171 related articles for article (PubMed ID: 18816780)
1. Is there a role for infliximab in severe ulcerative colitis?: the European experience.
Kohn A
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S234-5. PubMed ID: 18816780
[No Abstract] [Full Text] [Related]
2. Is there a role for infliximab in the treatment of severe ulcerative colitis?: the American experience.
Sandborn WJ
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S232-3. PubMed ID: 18816658
[No Abstract] [Full Text] [Related]
3. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
4. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
Wedekind S
MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
[No Abstract] [Full Text] [Related]
5. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs.
Thorlund K; Druyts E; Toor K; Mills EJ
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):693-700. PubMed ID: 25763862
[TBL] [Abstract][Full Text] [Related]
7. Treatment of ulcerative colitis with infliximab: are we there yet?
Fuss IJ
J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):247-9. PubMed ID: 15076622
[No Abstract] [Full Text] [Related]
8. [Infliximab as rescue therapy in severe steroid-resistant ulcerative colitis].
Martín de Carpi J; Vilar Escrigas P; Varea Calderón V
An Pediatr (Barc); 2008 Oct; 69(4):351-4. PubMed ID: 18928703
[TBL] [Abstract][Full Text] [Related]
9. [TNF-alpha antibody treatment and remission induction in ulcerative colitis: a review of a Cochrane review].
Bjerrum JT; Munck LC; Krogh-Madsen M; Nielsen OH
Ugeskr Laeger; 2007 Feb; 169(9):792-5. PubMed ID: 17355842
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment and management of severe ulcerative colitis.
Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
[TBL] [Abstract][Full Text] [Related]
12. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
Mocciaro F; Orlando A; Scimeca D; Cottone M
Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
[TBL] [Abstract][Full Text] [Related]
13. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
[TBL] [Abstract][Full Text] [Related]
14. Review and clinical perspectives for the use of infliximab in ulcerative colitis.
Panaccione R; Fedorak RN; Aumais G; Bernard EJ; Bernstein CN; Bitton A; Croitoru K; Dieleman LA; Enns R; Feagan BG; Franchimont D; Greenberg GR; Griffiths AM; Marshall JK; Pare P; Patel S; Penner R; Render C; Seidman E; Steinhart AH
Can J Gastroenterol; 2008 Mar; 22(3):261-72. PubMed ID: 18354755
[TBL] [Abstract][Full Text] [Related]
15. What is the optimal therapy for severe ulcerative colitis?
MacDermott RP; Green JA; Ashley CC
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S228-31. PubMed ID: 18816769
[No Abstract] [Full Text] [Related]
16. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use.
Tiemi J; Komati S; Sdepanian VL
J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321
[TBL] [Abstract][Full Text] [Related]
17. Acute severe colitis: infliximab and/or cyclosporine?
Fabro M; Szabo H; Terrosu G; Avellini C; Tabuso M; Fiorino G; Sorrentino D
Curr Drug Targets; 2011 Sep; 12(10):1448-53. PubMed ID: 21466485
[TBL] [Abstract][Full Text] [Related]
18. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
19. What is the optimal maintenance treatment for ulcerative colitis?
Cohen RD
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S236-7. PubMed ID: 18816679
[No Abstract] [Full Text] [Related]
20. Ulcerative colitis: conservative management and long-term effects.
Kühbacher T; Schreiber S; Fölsch UR
Langenbecks Arch Surg; 2004 Oct; 389(5):350-3. PubMed ID: 15133672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
